Gang Wang

Gang Wang, Ph.D., currently serves as Principal Scientist II at Schrödinger since May 2021, having progressed from Principal Scientist I. Prior experience includes roles as Senior Scientist and Scientist II at PTC Therapeutics, Inc. from October 2018 to May 2021, and as Scientist II and I at REVOLUTION Medicines from September 2017 to October 2018. Academic experience includes positions as a Graduate Teaching Assistant and Graduate Research Assistant at The University of Texas at Austin from August 2013 to July 2017, where key responsibilities involved supervising laboratory sessions and conducting research in organic chemistry. Gang Wang received a Ph.D. in Organic Chemistry from The University of Texas at Austin and holds a Bachelor of Science and a Master of Science in Pharmaceutical Science from Peking University.